Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Axogen, Inc. (AXGN) since 2014 are shown in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Axogen, Inc.. Table 2 shows the detailed insider transactions. This company's CIK number is 805928.
Total stock buying since 2014: $2,525,133.
Total stock sales since 2014: $74,765,223.
Total stock option exercises since 2014: $6,917,509.
| Insider Buying | Insider Sales | Option Exercises | ||||
|---|---|---|---|---|---|---|
| Year | Shares | Value | Shares | Value | Shares | Value |
| 2025 | 0 | $0 | 94,067 | $1,166,585 | 106,697 | $158,233 |
| 2024 | 2,525 | $26,512 | 118,082 | $980,899 | 264,806 | $0 |
| 2023 | 20,000 | $123,340 | 167,747 | $1,571,638 | 306,395 | $898,277 |
| 2022 | 0 | $0 | 82,581 | $931,435 | 319,517 | $461,390 |
| 2021 | 0 | $0 | 136,395 | $2,723,123 | 366,615 | $1,713,701 |
| 2020 | 0 | $0 | 120,783 | $1,642,993 | 278,388 | $1,127,707 |
| 2019 | 133,710 | $1,899,965 | 40,000 | $852,600 | 24,556 | $29,932 |
| 2018 | 5,000 | $184,450 | 316,513 | $9,347,598 | 568,268 | $1,758,969 |
| 2017 | 0 | $0 | 2,438,843 | $48,928,099 | 184,823 | $613,879 |
| 2016 | 32,666 | $244,994 | 531,057 | $4,065,768 | 36,571 | $79,171 |
| 2015 | 14,825 | $45,872 | 495,398 | $2,401,370 | 24,250 | $76,250 |
| 2014 | 0 | $0 | 50,000 | $153,115 | 0 | $0 |
| Trading Period | Insider Buying | Insider Sales | Option Exercises | |||
|---|---|---|---|---|---|---|
| year-month | Shares | Value | Shares | Value | Shares | Value |
| 2025-06 | 0 | $0 | 51,369 | $547,984 | 11,586 | $77,278 |
| 2025-05 | 0 | $0 | 22,587 | $254,059 | 12,850 | $80,955 |
| 2025-03 | 0 | $0 | 20,111 | $364,542 | 54,962 | $0 |
| 2025-02 | 0 | $0 | 0 | $0 | 27,299 | $0 |
| 2024-09 | 0 | $0 | 0 | $0 | 71,424 | $0 |
| 2024-08 | 2,525 | $26,512 | 0 | $0 | 0 | $0 |
| 2024-06 | 0 | $0 | 0 | $0 | 11,904 | $0 |
| 2024-03 | 0 | $0 | 118,082 | $980,899 | 181,478 | $0 |
| 2023-12 | 0 | $0 | 12,500 | $93,875 | 0 | $0 |
| 2023-09 | 10,000 | $62,240 | 0 | $0 | 0 | $0 |
| 2023-08 | 10,000 | $61,100 | 0 | $0 | 0 | $0 |
| 2023-06 | 0 | $0 | 41,980 | $365,016 | 38,754 | $0 |
| 2023-05 | 0 | $0 | 7,468 | $68,817 | 28,750 | $265,075 |
| 2023-03 | 0 | $0 | 0 | $0 | 113,255 | $0 |
| 2023-02 | 0 | $0 | 14,550 | $136,188 | 20,940 | $105,537 |
| 2023-01 | 0 | $0 | 91,249 | $907,742 | 104,696 | $527,665 |
| 2022-12 | 0 | $0 | 0 | $0 | 33,125 | $101,800 |
| 2022-11 | 0 | $0 | 36,649 | $454,630 | 0 | $0 |
| 2022-08 | 0 | $0 | 45,932 | $476,805 | 0 | $0 |
| 2022-07 | 0 | $0 | 0 | $0 | 83,000 | $280,540 |
| 2022-06 | 0 | $0 | 0 | $0 | 92,040 | $0 |
| 2022-03 | 0 | $0 | 0 | $0 | 96,352 | $0 |
| 2022-02 | 0 | $0 | 0 | $0 | 15,000 | $79,050 |
| 2021-12 | 0 | $0 | 0 | $0 | 29,875 | $36,700 |
| Trade Date | Insider Name | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2025-06-10 | Tyndall Joseph A. (Director) | Sale | 26,931 | 10.72 | 288,700 |
| 2025-06-10 | Tyndall Joseph A. (Director) | Option Ex | 11,586 | 6.67 | 77,278 |
| 2025-06-09 | Weiler Kathy Johnson (Director) | Sale | 4,073 | 10.61 | 43,214 |
| 2025-06-09 | Levine Alan M | Sale | 4,073 | 10.61 | 43,214 |
| 2025-06-09 | Burke William P. Mr. (Director) | Sale | 4,073 | 10.61 | 43,214 |
| 2025-06-09 | Johnson John (Director) | Sale | 4,073 | 10.61 | 43,214 |
| 2025-06-09 | Wendell Amy Mcbride | Sale | 4,073 | 10.61 | 43,214 |
| 2025-06-09 | Neels Guido J | Sale | 4,073 | 10.61 | 43,214 |
| 2025-05-22 | Tyndall Joseph A. (Director) | Sale | 20,062 | 11.20 | 224,694 |
| 2025-05-22 | Tyndall Joseph A. (Director) | Option Ex | 12,850 | 6.30 | 80,955 |
| 2025-05-19 | Tyndall Joseph A. (Director) | Sale | 2,525 | 11.63 | 29,365 |
| 2025-03-19 | Devinney Erick Wayne (Chief Innovation Officer) | Sale | 15,111 | 17.50 | 264,442 |
| 2025-03-16 | Devinney Erick Wayne (Chief Innovation Officer) | Option Ex | 32,462 | .00 | 0 |
| 2025-03-03 | Wendell Amy Mcbride | Sale | 5,000 | 20.02 | 100,100 |
| 2025-03-01 | Began Marc A (EVP & General Counsel) | Option Ex | 22,500 | .00 | 0 |
| 2025-02-28 | Devinney Erick Wayne (Chief Innovation Officer) | Option Ex | 24,799 | .00 | 0 |
| 2025-02-22 | Kemp Jens (Chief Marketing Officer) | Option Ex | 2,500 | .00 | 0 |
| 2024-09-01 | Tyndall Joseph A. (Director) | Option Ex | 11,904 | .00 | 0 |
| 2024-09-01 | Levine Alan M | Option Ex | 11,904 | .00 | 0 |
| 2024-09-01 | Burke William P. Mr. (Director) | Option Ex | 11,904 | .00 | 0 |
| 2024-09-01 | Johnson John (Director) | Option Ex | 11,904 | .00 | 0 |
| 2024-09-01 | Wendell Amy Mcbride | Option Ex | 11,904 | .00 | 0 |
| 2024-09-01 | Neels Guido J | Option Ex | 11,904 | .00 | 0 |
| 2024-08-08 | Tyndall Joseph A. (Director) | Buy | 2,525 | 10.50 | 26,512 |
| 2024-06-04 | Freitag Gregory Gene | Option Ex | 11,904 | .00 | 0 |
| 2024-03-21 | Scopelianos Angelo (Chief R&D Officer) | Sale | 6,881 | 7.68 | 52,846 |
| 2024-03-21 | Scopelianos Angelo (Chief R&D Officer) | Option Ex | 2,500 | .00 | 0 |
| 2024-03-21 | Donovan Michael Patrick (VP Operations) | Sale | 6,033 | 7.68 | 46,333 |
| 2024-03-21 | Devinney Erick Wayne (Chief Innovation Officer) | Sale | 4,578 | 7.68 | 35,159 |
| 2024-03-21 | Zaderej Karen L. (CEO) | Sale | 39,280 | 7.68 | 301,670 |
| 2024-03-16 | Scopelianos Angelo (Chief R&D Officer) | Option Ex | 25,406 | .00 | 0 |
| 2024-03-16 | Donovan Michael Patrick (VP Operations) | Option Ex | 24,575 | .00 | 0 |
| 2024-03-16 | Devinney Erick Wayne (Chief Innovation Officer) | Option Ex | 18,675 | .00 | 0 |
| 2024-03-16 | Zaderej Karen L. (CEO) | Option Ex | 110,322 | .00 | 0 |
| 2024-03-07 | Donovan Michael Patrick (VP Operations) | Sale | 36,310 | 8.81 | 319,891 |
| 2024-03-07 | Freitag Gregory Gene | Sale | 25,000 | 9.00 | 225,000 |
| 2023-12-11 | Mariani Peter J (EVP & Chief Financial Officer) | Sale | 12,500 | 7.51 | 93,875 |
| 2023-09-06 | Wendell Amy Mcbride | Buy | 10,000 | 6.22 | 62,240 |
| 2023-08-16 | Neels Guido J | Buy | 10,000 | 6.11 | 61,100 |
| 2023-06-01 | Levine Alan M | Option Ex | 6,459 | .00 | 0 |
| 2023-06-01 | Freitag Gregory Gene | Sale | 41,980 | 8.70 | 365,016 |
| 2023-06-01 | Freitag Gregory Gene | Option Ex | 6,459 | .00 | 0 |
| 2023-06-01 | Johnson John | Option Ex | 6,459 | .00 | 0 |
| 2023-06-01 | Wendell Amy Mcbride | Option Ex | 6,459 | .00 | 0 |
| 2023-06-01 | Neels Guido J | Option Ex | 6,459 | .00 | 0 |
| 2023-06-01 | Thomas Paul | Option Ex | 6,459 | .00 | 0 |
| 2023-05-23 | Freitag Gregory Gene | Sale | 7,468 | 9.21 | 68,817 |
| 2023-05-12 | Wendell Amy Mcbride | Option Ex | 28,750 | 9.22 | 265,075 |
| 2023-03-16 | Ottinger Bradley (General Counsel and CCO) | Option Ex | 8,463 | .00 | 0 |
| 2023-03-16 | Scopelianos Angelo (Chief R&D Officer) | Option Ex | 13,750 | .00 | 0 |
| 2023-03-16 | Donovan Michael Patrick (VP Operations) | Option Ex | 8,900 | .00 | 0 |
| 2023-03-16 | Martinez Maria D. (Chief Human Resources Officer) | Option Ex | 14,517 | .00 | 0 |
| 2023-03-16 | Devinney Erick Wayne (VP Peripheral Nerve Science) | Option Ex | 8,900 | .00 | 0 |
| 2023-03-16 | Zaderej Karen L. (CEO) | Option Ex | 37,975 | .00 | 0 |
| 2023-03-16 | Mariani Peter J (EVP & Chief Financial Officer) | Option Ex | 20,750 | .00 | 0 |
| 2023-02-01 | Mariani Peter J (EVP & Chief Financial Officer) | Sale | 14,550 | 9.36 | 136,188 |
| 2023-02-01 | Mariani Peter J (EVP & Chief Financial Officer) | Option Ex | 20,940 | 5.04 | 105,537 |
| 2023-01-31 | Mariani Peter J (EVP & Chief Financial Officer) | Sale | 14,320 | 9.55 | 136,756 |
| 2023-01-31 | Mariani Peter J (EVP & Chief Financial Officer) | Option Ex | 20,939 | 5.04 | 105,532 |
| 2023-01-30 | Mariani Peter J (EVP & Chief Financial Officer) | Sale | 14,111 | 9.69 | 136,735 |
| 2023-01-30 | Mariani Peter J (EVP & Chief Financial Officer) | Option Ex | 20,939 | 5.04 | 105,532 |
| 2023-01-27 | Mariani Peter J (EVP & Chief Financial Officer) | Sale | 20,940 | 10.16 | 212,750 |
| 2023-01-27 | Mariani Peter J (EVP & Chief Financial Officer) | Option Ex | 20,940 | 5.04 | 105,537 |
| 2023-01-26 | Mariani Peter J (EVP & Chief Financial Officer) | Sale | 20,939 | 9.90 | 207,296 |
| 2023-01-26 | Mariani Peter J (EVP & Chief Financial Officer) | Option Ex | 20,939 | 5.04 | 105,532 |
| 2023-01-25 | Mariani Peter J (EVP & Chief Financial Officer) | Sale | 20,939 | 10.23 | 214,205 |
| 2023-01-25 | Mariani Peter J (EVP & Chief Financial Officer) | Option Ex | 20,939 | 5.04 | 105,532 |
| 2022-12-27 | Billet Isabelle (Chief Strategy and BD Officer) | Option Ex | 1,150 | .00 | 0 |
| 2022-12-27 | Scopelianos Angelo (Chief R&D Officer) | Option Ex | 1,150 | .00 | 0 |
| 2022-12-27 | Donovan Michael Patrick (VP Operations) | Option Ex | 1,150 | .00 | 0 |
| 2022-12-27 | Martinez Maria D. (Chief Human Resources Officer) | Option Ex | 1,150 | .00 | 0 |
| 2022-12-27 | Devinney Erick Wayne (VP Peripheral Nerve Science) | Option Ex | 20,750 | 2.54 | 101,800 |
| 2022-12-27 | Zaderej Karen L. (CEO) | Option Ex | 4,400 | .00 | 0 |
| 2022-12-27 | Mariani Peter J (EVP & Chief Financial Officer) | Option Ex | 2,625 | .00 | 0 |
| 2022-11-16 | Mariani Peter J (EVP & Chief Financial Officer) | Sale | 10,649 | 11.88 | 126,510 |
| 2022-11-14 | Freitag Gregory Gene | Sale | 13,000 | 12.74 | 165,620 |
| 2022-11-08 | Freitag Gregory Gene | Sale | 13,000 | 12.50 | 162,500 |
| 2022-08-10 | Freitag Gregory Gene | Sale | 8,886 | 9.70 | 86,158 |
| 2022-08-08 | Freitag Gregory Gene | Sale | 13,046 | 10.37 | 135,287 |
| 2022-08-04 | Freitag Gregory Gene | Sale | 24,000 | 10.64 | 255,360 |
| 2022-07-25 | Freitag Gregory Gene | Option Ex | 83,000 | 3.38 | 280,540 |
| 2022-06-01 | Ottinger Bradley (General Counsel and CCO) | Option Ex | 31,000 | .00 | 0 |
| 2022-06-01 | Levine Alan M | Option Ex | 6,072 | .00 | 0 |
| 2022-06-01 | Gold Mark Stephen | Option Ex | 6,072 | .00 | 0 |
| 2022-06-01 | Freitag Gregory Gene | Option Ex | 6,072 | .00 | 0 |
| 2022-06-01 | Wendell Amy Mcbride | Option Ex | 6,072 | .00 | 0 |
| 2022-06-01 | Neels Guido J | Option Ex | 6,072 | .00 | 0 |
| 2022-03-30 | Blackford Quentin S. | Option Ex | 3,036 | .00 | 0 |
| 2022-03-16 | Sandberg Eric (Chief Commercial Officer) | Option Ex | 6,000 | .00 | 0 |
| 2022-03-16 | Billet Isabelle (Chief Strategy and BD Officer) | Option Ex | 8,500 | .00 | 0 |
| 2022-03-16 | Scopelianos Angelo (Chief R&D Officer) | Option Ex | 11,000 | .00 | 0 |
| 2022-03-16 | Donovan Michael Patrick (VP Operations) | Option Ex | 6,000 | .00 | 0 |
| 2022-03-16 | Martinez Maria D. (Chief Human Resources Officer) | Option Ex | 12,866 | .00 | 0 |
| 2022-03-16 | Devinney Erick Wayne (VP Peripheral Nerve Science) | Option Ex | 6,000 | .00 | 0 |
| 2022-03-16 | Friedman Mark Louis (VP Regulatory Affairs & Policy) | Option Ex | 6,000 | .00 | 0 |
| 2022-03-16 | Zaderej Karen L. (CEO) | Option Ex | 25,950 | .00 | 0 |
| 2022-03-16 | Mariani Peter J (EVP & Chief Financial Officer) | Option Ex | 11,000 | .00 | 0 |
| 2022-02-22 | Donovan Michael Patrick (VP Operations) | Option Ex | 15,000 | 5.27 | 79,050 |
| 2021-12-27 | Billet Isabelle (Chief Strategy and BD Officer) | Option Ex | 1,150 | .00 | 0 |
| 2021-12-27 | Scopelianos Angelo (Chief R&D Officer) | Option Ex | 1,150 | .00 | 0 |
| 2021-12-27 | Donovan Michael Patrick (VP Operations) | Option Ex | 1,150 | .00 | 0 |
| 2021-12-27 | Martinez Maria D. (Chief Human Resources Officer) | Option Ex | 1,150 | .00 | 0 |
| 2021-12-27 | Devinney Erick Wayne (VP Peripheral Nerve Science) | Option Ex | 750 | .00 | 0 |
| 2021-12-27 | Friedman Mark Louis (VP Regulatory Affairs & Policy) | Option Ex | 1,150 | .00 | 0 |
| 2021-12-27 | Zaderej Karen L. (CEO) | Option Ex | 4,400 | .00 | 0 |
| 2021-12-27 | Mariani Peter J (EVP & Chief Financial Officer) | Option Ex | 2,625 | .00 | 0 |
| 2021-12-20 | Donovan Michael Patrick (VP Operations) | Option Ex | 375 | .00 | 0 |
| 2021-12-20 | Devinney Erick Wayne (VP Peripheral Nerve Science) | Option Ex | 575 | .00 | 0 |
| 2021-12-20 | Friedman Mark Louis (VP Regulatory Affairs & Policy) | Option Ex | 375 | .00 | 0 |
| 2021-12-20 | Zaderej Karen L. (CEO) | Option Ex | 3,125 | .00 | 0 |
| 2021-12-20 | Mariani Peter J (EVP & Chief Financial Officer) | Option Ex | 1,900 | .00 | 0 |
| 2021-12-15 | Devinney Erick Wayne (VP Peripheral Nerve Science) | Option Ex | 10,000 | 3.67 | 36,700 |
| 2021-11-24 | Zaderej Karen L. (CEO) | Option Ex | 52,375 | 8.95 | 468,756 |
| 2021-08-10 | Zaderej Karen L. (CEO) | Option Ex | 75,000 | 5.09 | 381,750 |
| 2021-08-06 | Zaderej Karen L. (CEO) | Sale | 41,000 | 18.79 | 770,267 |
| 2021-07-21 | Donovan Michael Patrick (VP Operations) | Sale | 1,935 | 20.04 | 38,777 |
| 2021-06-04 | Martinez Maria D. (Chief Human Resources Officer) | Sale | 2,652 | 18.86 | 50,016 |
| 2021-06-04 | Freitag Gregory Gene | Option Ex | 24,000 | 3.67 | 88,080 |
| 2021-06-01 | Levine Alan M | Option Ex | 6,173 | .00 | 0 |
| 2021-06-01 | Blackford Quentin S. | Option Ex | 6,173 | .00 | 0 |
| 2021-06-01 | Gold Mark Stephen | Option Ex | 6,173 | .00 | 0 |
| 2021-06-01 | Wendell Amy Mcbride | Option Ex | 6,173 | .00 | 0 |
| 2021-06-01 | Neels Guido J | Option Ex | 6,173 | .00 | 0 |
| 2021-04-16 | Zaderej Karen L. (CEO) | Option Ex | 100,000 | 5.09 | 509,000 |
| 2021-03-25 | Zaderej Karen L. (CEO) | Option Ex | 34,500 | 3.67 | 126,615 |
| 2021-02-25 | Freitag Gregory Gene | Sale | 24,000 | 22.06 | 529,440 |
| 2021-02-18 | Donovan Michael Patrick (VP Operations) | Sale | 1,808 | 19.15 | 34,623 |
| 2021-02-05 | Donovan Michael Patrick (VP Operations) | Option Ex | 20,000 | 5.14 | 102,800 |
| 2021-01-08 | Zaderej Karen L. (CEO) | Sale | 65,000 | 20.00 | 1,300,000 |
| 2020-12-30 | Donovan Michael Patrick (VP Operations) | Sale | 1,733 | 17.48 | 30,292 |
| 2020-12-29 | Billet Isabelle (Chief Strategy and BD Officer) | Sale | 649 | 17.81 | 11,558 |
| 2020-12-29 | Scopelianos Angelo (VP Research & Development) | Sale | 567 | 17.81 | 10,098 |
| 2020-12-29 | Donovan Michael Patrick (VP Operations) | Sale | 567 | 17.81 | 10,098 |
| 2020-12-29 | Martinez Maria D. (Chief Human Resources Officer) | Sale | 567 | 17.81 | 10,098 |
| 2020-12-29 | Devinney Erick Wayne (VP, Clinical&Translational Sc) | Sale | 371 | 17.81 | 6,607 |
| 2020-12-29 | Friedman Mark Louis (VP,Regulatory & Quality) | Sale | 567 | 17.81 | 10,098 |
| 2020-12-29 | Zaderej Karen L. (CEO) | Sale | 3,500 | 17.81 | 62,334 |
| 2020-12-29 | Freitag Gregory Gene | Sale | 916 | 17.81 | 16,313 |
| 2020-12-29 | Mariani Peter J (Chief Financial Officer) | Sale | 1,293 | 17.81 | 23,028 |
| 2020-12-23 | Zaderej Karen L. (CEO) | Option Ex | 19,375 | 4.81 | 93,193 |
| 2020-12-22 | Donovan Michael Patrick (VP Operations) | Sale | 279 | 17.19 | 4,796 |
| 2020-12-21 | Donovan Michael Patrick (VP Operations) | Sale | 96 | 16.42 | 1,576 |
| 2020-12-21 | Devinney Erick Wayne (VP, Clinical&Translational Sc) | Sale | 147 | 16.42 | 2,413 |
| 2020-12-21 | Friedman Mark Louis (VP,Regulatory & Quality) | Sale | 96 | 16.42 | 1,576 |
| 2020-12-21 | Zaderej Karen L. (CEO) | Sale | 1,275 | 16.42 | 20,935 |
| 2020-12-21 | Freitag Gregory Gene | Sale | 379 | 16.42 | 6,223 |
| 2020-12-21 | Mariani Peter J (Chief Financial Officer) | Sale | 481 | 16.42 | 7,898 |
| 2020-12-15 | Devinney Erick Wayne (VP, Clinical&Translational Sc) | Option Ex | 15,000 | 4.81 | 72,150 |
| 2020-12-03 | Friedman Mark Louis (VP,Regulatory & Quality) | Option Ex | 3,812 | 4.24 | 16,162 |
| 2020-11-09 | Donovan Michael Patrick (VP Operations) | Sale | 17,617 | 15.00 | 264,255 |
| 2020-11-09 | Zaderej Karen L. (CEO) | Sale | 14,000 | 14.53 | 203,420 |
| 2020-10-30 | Mariani Peter J (Chief Financial Officer) | Sale | 75,683 | 12.41 | 939,377 |
| 2020-10-30 | Mariani Peter J (Chief Financial Officer) | Option Ex | 60,000 | 5.04 | 302,400 |
| 2020-09-15 | Freitag Gregory Gene | Option Ex | 13,046 | 3.67 | 47,878 |
| 2020-05-29 | Freitag Gregory Gene (General Counsel) | Option Ex | 125,000 | 3.50 | 437,500 |
| 2020-05-28 | Donovan Michael Patrick (VP Operations) | Option Ex | 15,000 | 4.41 | 66,075 |
| 2020-04-28 | Devinney Erick Wayne (VP, Clinical&Translational Sc) | Option Ex | 2,530 | .27 | 683 |
| 2020-04-16 | Zaderej Karen L. (CEO) | Option Ex | 11,625 | 4.81 | 55,916 |
| 2020-01-01 | Rudelius Robert James | Option Ex | 13,000 | 2.75 | 35,750 |
| 2019-10-08 | Donovan Michael Patrick (VP Operations) | Option Ex | 6,500 | 3.85 | 25,057 |
| 2019-08-14 | Martinez Maria D. (Chief Human Resources Officer) | Buy | 4,000 | 15.13 | 60,520 |
| 2019-08-13 | Billet Isabelle (Chief Strategy and BD Officer) | Buy | 16,905 | 15.11 | 255,348 |
| 2019-08-12 | Blackford Quentin S. | Buy | 14,170 | 14.10 | 199,797 |
| 2019-08-09 | Blackford Quentin S. | Buy | 1,365 | 13.09 | 17,861 |
| 2019-08-09 | Gold Mark Stephen | Buy | 4,000 | 13.07 | 52,272 |
| 2019-08-09 | Zaderej Karen L. (CEO) | Buy | 75,000 | 13.50 | 1,012,425 |
| 2019-06-13 | Donovan Michael Patrick (VP Operations) | Sale | 20,000 | 20.00 | 400,000 |
| 2019-06-13 | Wendell Amy Mcbride | Buy | 5,000 | 20.25 | 101,250 |
| 2019-05-29 | Zaderej Karen L. (CEO) | Option Ex | 18,056 | .27 | 4,875 |
| 2019-05-13 | Hansen David K (VP Finance & Treasurer) | Sale | 20,000 | 22.63 | 452,600 |
| 2018-11-30 | Freitag Gregory Gene (General Counsel) | Sale | 45,000 | 33.00 | 1,485,000 |
| 2018-11-19 | Zaderej Karen L. (CEO) | Option Ex | 100,000 | 2.74 | 274,000 |
| 2018-11-15 | Freitag Gregory Gene (General Counsel) | Sale | 20,000 | 32.25 | 645,000 |
| 2018-11-14 | Zaderej Karen L. (CEO) | Sale | 12,000 | 32.93 | 395,160 |
| 2018-11-13 | Devinney Erick Wayne (VP, Clinical&Translational Sc) | Option Ex | 35,274 | 1.50 | 53,087 |
| 2018-11-13 | Zaderej Karen L. (CEO) | Sale | 13,000 | 33.42 | 434,460 |
| 2018-09-20 | Grooms Jamie Mark | Option Ex | 12,494 | 1.51 | 18,865 |
| 2018-08-14 | Wendell Amy Mcbride | Buy | 5,000 | 36.89 | 184,450 |
| 2018-08-07 | Mccarrey Shawn F (SVP Sales) | Option Ex | 55,000 | 3.67 | 201,850 |
| 2018-08-02 | Zaderej Karen L. (CEO) | Option Ex | 175,000 | 2.74 | 479,500 |
| 2018-06-08 | Rudelius Robert James | Option Ex | 12,000 | 2.75 | 33,000 |
| 2018-06-01 | Gold Mark Stephen | Option Ex | 15,000 | 14.85 | 222,750 |
| 2018-05-16 | Mccarrey Shawn F (SVP Sales) | Sale | 10,000 | 43.47 | 434,700 |
| 2018-03-26 | Donovan Michael Patrick (VP Operations) | Option Ex | 30,000 | 2.74 | 82,200 |
| 2018-03-22 | Hansen David K (VP Finance & Treasurer) | Option Ex | 36,500 | 2.75 | 100,192 |
| 2018-03-21 | Freitag Gregory Gene (General Counsel & SVP BD) | Option Ex | 31,000 | 3.63 | 112,685 |
| 2018-03-01 | Freitag Gregory Gene (General Counsel & SVP BD) | Option Ex | 36,000 | 2.74 | 98,640 |
| 2018-02-21 | Grooms Jamie Mark (Director) | Sale | 57,406 | 28.40 | 1,630,330 |
| 2018-02-20 | Grooms Jamie Mark (Director) | Sale | 36,740 | 27.90 | 1,025,046 |
| 2018-02-16 | Grooms Jamie Mark (Director) | Sale | 26,655 | 27.35 | 729,014 |
| 2018-02-15 | Grooms Jamie Mark (VP, CFO) | Sale | 43,403 | 27.11 | 1,176,655 |
| 2018-02-14 | Grooms Jamie Mark (VP, CFO) | Sale | 42,009 | 26.71 | 1,122,270 |
| 2018-02-13 | Grooms Jamie Mark (VP, CFO) | Sale | 10,300 | 26.21 | 269,963 |
| 2017-12-12 | Grooms Jamie Mark | Sale | 16,585 | 26.34 | 436,848 |
| 2017-12-11 | Grooms Jamie Mark | Sale | 21,820 | 26.35 | 574,957 |
| 2017-12-08 | Grooms Jamie Mark | Sale | 31,805 | 26.37 | 838,697 |
| 2017-12-07 | Grooms Jamie Mark | Sale | 31,200 | 26.50 | 826,800 |
| 2017-12-06 | Grooms Jamie Mark | Sale | 21,290 | 26.22 | 558,223 |
| 2017-11-20 | Essex Woodlands Fund Ix, L.p. (10% Owner) | Sale | 1,150,000 | 19.74 | 22,701,000 |
| 2017-11-20 | Neels Guido J (Director) | Sale | 1,150,000 | 19.74 | 22,701,000 |
| 2017-11-13 | Gold Mark Stephen | Option Ex | 15,000 | 5.09 | 76,350 |
| 2017-11-01 | Grooms Jamie Mark | Option Ex | 14,379 | .27 | 3,882 |
| 2017-10-24 | Friedman Mark Louis (VP,Regulatory & Quality) | Option Ex | 67,767 | 3.55 | 240,437 |
| 2017-09-25 | Freitag Gregory Gene (General Counsel & SVP BD) | Option Ex | 10,000 | 2.74 | 27,400 |
| 2017-09-11 | Rudelius Robert James | Sale | 16,143 | 18.00 | 290,574 |
| 2017-09-08 | Rudelius Robert James | Option Ex | 20,000 | 3.50 | 70,000 |
| 2017-08-27 | Freitag Gregory Gene (General Counsel & SVP BD) | Option Ex | 23,000 | 2.74 | 63,020 |
| 2017-05-30 | Gold Mark Stephen | Option Ex | 5,000 | 8.95 | 44,750 |
| 2017-05-22 | Gold Mark Stephen | Option Ex | 15,000 | 4.81 | 72,150 |
| 2017-03-14 | Donovan Michael Patrick (VP Operations) | Option Ex | 9,659 | 1.50 | 14,536 |
| 2017-03-14 | Devinney Erick Wayne (VP, Clinical&Translational Sc) | Option Ex | 5,018 | .27 | 1,354 |
| 2016-12-30 | Freitag Gregory Gene (General Counsel & SVP BD) | Option Ex | 23,000 | 2.74 | 63,020 |
| 2016-10-07 | Leach Kevin (Vice President Marketing) | Buy | 2,000 | 7.50 | 15,000 |
| 2016-10-07 | Zaderej Karen L. (CEO) | Buy | 10,000 | 7.50 | 75,000 |
| 2016-10-07 | Engels John P (VP) | Buy | 4,000 | 7.50 | 30,000 |
| 2016-10-07 | Wendell Amy Mcbride | Buy | 13,333 | 7.50 | 99,997 |
| 2016-10-07 | Mariani Peter J (Chief Financial Officer) | Buy | 3,333 | 7.50 | 24,997 |
| 2016-08-17 | Gold Mark Stephen | Option Ex | 3,750 | 3.60 | 13,500 |
| 2016-08-09 | Mandato Joseph M (Director) | Sale | 42,168 | 8.30 | 349,994 |
| 2016-08-08 | Mandato Joseph M (Director) | Sale | 107,450 | 8.63 | 927,293 |
| 2016-07-21 | Deerfield Special Situations Fund, L.p. | Sale | 102,136 | 6.70 | 684,311 |
| 2016-07-18 | Deerfield Special Situations Fund, L.p. | Sale | 41,425 | 6.87 | 284,589 |
| 2016-07-15 | Deerfield Special Situations Fund, L.p. | Sale | 31,788 | 7.32 | 232,688 |
| 2016-07-14 | Deerfield Special Situations Fund, L.p. | Sale | 206,090 | 7.70 | 1,586,893 |
| 2016-05-31 | Hansen David K (Chief Accounting Officer) | Option Ex | 9,821 | .27 | 2,651 |
| 2015-11-12 | Gold Mark Stephen (Director) | Option Ex | 11,250 | 3.60 | 40,500 |
| 2015-11-06 | Gold Mark Stephen (Director) | Sale | 6,013 | 5.70 | 34,274 |
| 2015-09-18 | Deerfield Special Situations Fund, L.p. | Sale | 345,000 | 5.50 | 1,897,845 |
| 2015-09-08 | Gold Mark Stephen (Director) | Option Ex | 13,000 | 2.75 | 35,750 |
| 2015-06-03 | Mandato Joseph M (Director) | Buy | 6,500 | 3.10 | 20,150 |
| 2015-06-02 | Johnston Lee Robert Jr (Chief Finacial Officer) | Buy | 5,000 | 3.06 | 15,325 |
| 2015-05-27 | Zaderej Karen L. (Chief Executive Officer) | Buy | 3,325 | 3.13 | 10,397 |
| 2015-04-08 | Deerfield Special Situations Fund, L.p. | Sale | 144,385 | 3.25 | 469,251 |
| 2014-12-11 | Mandato Joseph M (Director) | Sale | 2,342 | 3.15 | 7,377 |
| 2014-12-10 | Mandato Joseph M (Director) | Sale | 47,658 | 3.06 | 145,738 |
Insider trading activities including stock purchases, stock sales, and option exercises of AXGN listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Axogen, Inc. (symbol AXGN, CIK number 805928) see the Securities and Exchange Commission (SEC) website.